Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2/3 1

Status

Unknown 2Recruiting 2Completed 2

Sponsor Class

OTHER 6INDUSTRY 1

Study Type

Observational 4Interventional 2

Sponsor

Cancer Type

Myeloid 6

Conditions

Myelodysplastic Syndromes 999Leukemia, Myeloid, Acute 826Leukemia, Myelogenous, Chronic, BCR-ABL Positive 532Leukemia 519Precursor Cell Lymphoblastic Leukemia-Lymphoma 501Myeloproliferative Disorders 438Lymphoma, Non-Hodgkin 339Multiple Myeloma 327Hodgkin Disease 313Leukemia, Lymphocytic, Chronic, B-Cell 304Leukemia, Myelomonocytic, Chronic 299Primary Myelofibrosis 285Lymphoma 267Leukemia, Myeloid, Chronic-Phase 254Leukemia, Myeloid, Accelerated Phase 208Blast Crisis 208Lymphoma, Mantle-Cell 206Lymphoma, Follicular 204Burkitt Lymphoma 200Lymphoma, Large B-Cell, Diffuse 192Lymphoma, B-Cell, Marginal Zone 184Congenital Abnormalities 166Lymphoma, Large-Cell, Immunoblastic 165Polycythemia Vera 162Myelodysplastic-Myeloproliferative Diseases 159Neoplasms, Plasma Cell 152Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 145Anemia, Refractory, with Excess of Blasts 127Thrombocythemia, Essential 125Lymphoma, T-Cell, Cutaneous 124

Interventions

Imatinib Mesylate 1Cladribine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
OTHER × Mast Cell Activation Disorders × Myeloid × Clear all
NCT06186856 2026-04-22

DATAMAST

Imagine Institute

Recruiting
13,000 enrolled
Myeloid

Mast Cell Activation Disorders, Mastocytosis

NCT06466889 2024-06-26

MastoR

University of Zurich

Recruiting
400 enrolled
Myeloid

Mast Cell Activation Disorders, Mastocytosis

NCT04615663 2020-11-04

MCD&BuDi

University Hospital, Toulouse

Unknown
200 enrolled
Myeloid

Mast Cell Activation Disorders, Mastocytosis

NCT00336076 2016-11-07

Molecular Mechanisms and Diagnosis of Mastocytosis

University of Michigan

Completed
136 enrolled
Myeloid

Mast Cell Activation Disorders, Anaphylaxis, Mastocytosis, Piebaldism

NCT01297777 2016-08-29

Imatinib in KIT-negative Systemic Mastocytosis

Hospital Virgen de la Salud

Phase 4 Completed
10 enrolled
Myeloid

Mast Cell Activation Disorders, Mastocytosis, Mastocytosis, Systemic

NCT01602939 2016-08-29

Cladribine Plus Pegylated Interpheron Alfa-2a in Systemic Mastocytosis

Hospital Virgen de la Salud

Phase 2/3 Unknown
10 enrolled
Myeloid

Mast Cell Activation Disorders, Mastocytosis, Mastocytosis, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡